Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

December 27, 2023

https://www.globenewswire.com/news-release/2023/12/26/2801155/33333/en/Coherus-Announces-FDA-Approval-of-UDENYCA-ONBODY-a-Novel-and-Proprietary-State-of-the-Art-Delivery-System-for-pegfilgrastim-cbqv.html

– Innovative design enables five-minute pegfilgrastim delivery time –

– Unique, automatic, retractable needle mechanism engineered to maximize safety and comfort for cancer patients receiving pegfilgrastim –

Read more at globenewswire.com

Related news for (CHRS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.